Categories Earnings, Health Care

Neos Therapeutics (NASDAQ: NEOS): Q4 2019 Earnings Snapshot

— Neos Therapeutics Inc. (NASDAQ: NEOS) reported a fourth-quarter 2019 loss of $0.07 per share versus a loss of $0.03 per share expected.

— Total product revenue grew by 9.1% to $16.8 million versus $20.57 million expected.

Earnings Update by AlphaStreet

— The bottom line reflected the evolution of the commercial strategy and the company’s focus on both operational productivity and expense management.

— The company reported growth in net product sales and net revenue per pack for its two core commercial attention deficit hyperactivity disorder (ADHD) products, Adzenys XR-ODT and Cotempla XR-ODT.

— During the fourth quarter of 2019, the company substantially expanded the number of participating pharmacies in the Neos RxConnect network to about 500 pharmacies, including one regional pharmacy chain, as of December 31, 2019.

— Neos recently agreed with a third-party to commercialize Neos’ ADHD portfolio in Puerto Rico. The commercial launch is anticipated to occur in the second quarter of 2020.

— The company achieved top-line results from the NT0502 Phase 1 pilot pharmacokinetic study and plans to initiate an ascending dose study in the second half of the year. This underserves patients struggling with chronic sialorrhea, otherwise known as excessive drooling, across numerous debilitating CNS disorders.

Listen to on-demand earnings calls and hear how management responds to analysts’ questions

Most Popular

Infographic: Key highlights from Campbell Soup Company’s (CPB) Q1 2023 earnings results

Campbell Soup Company (NYSE: CPB) reported first quarter 2023 earnings results today. Net sales increased 15% year-over-year to $2.57 billion. Organic sales growth was 15%. Net earnings attributable to Campbell Soup

Cancer drug maker Felicitex prepares for IPO. Here’s all you need to know

Fewer companies filed for initial public offering this year, compared to 2021 when the market witnessed a record number of IPOs. With only a few weeks left for the year

Chipotle Mexican Grill (CMG): A few points to keep in mind if you have an eye on this restaurant chain

Shares of Chipotle Mexican Grill Inc. (NYSE: CMG) were down 3% on Tuesday. The stock has dropped 13% year-to-date but there is still a positive sentiment in general about its

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top